KarenQuillenMD

Blood Banking & Transfusion Medicine, Hematologic Oncology

Professor, Pathology & Laboratory Medicine, Boston University School of Medicine

Dr. Quillen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
670 Albany St
3rd Floor Room 310
Boston, MA 02118
Phone+1 617-414-5314

Fax+1 617-414-5315

Dr. Karen Quillen is a hematologist in Boston, MA and is affiliated with Boston Medical Center. She received her medical degree from Queen's University at Kingston and has been in practice 26 years. She specializes in hematology and transfusion medicine.

PubMed

14 citations
Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
Shayna Sarosiek, Luke Zheng, J. Mark Sloan, Karen Quillen, Dina Brauneis
Blood Cancer Journal. 2020-09-01
440 citations
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
Martha Skinner, Vaishali Sanchorawala, David C. Seldin, Laura M. Dember, Rodney H. Falk
Annals of Internal Medicine. 2004-01-20
88 citations
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.
Vaishali Sanchorawala, Fangui Sun, Karen Quillen, J. Mark Sloan, John L. Berk
Blood. 2015-11-12

Abstracts/Posters

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results o...
Karen Quillen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019